Matrix USA Rating Changes 10/2
More News related to AMN
- Matrix USA Rating Changes 10/2
- Ameron (AMN) Announces Quarterly Dividend of 30c
- Unusual 11 Mid-Day Movers 9/25: TOPS, FRE, FNM, PCOP Higher; AMN, CRAI, PPC, MTN Lower
- Ameron (AMN) Misses Street's Q3 Estimates
- Ameron (AMN) Tops EPS Views; Revs Light
More News related to BHE
- Collins Stewart Downgrades Benchmark Electronics (BHE) to Sell
- Benchmark Electronics Announces Retirement of Co-Founders Don Nigbor and Steve Barton
- Benchmark Electronics (BHE) Misses Q3 EPS by 1c; Guides Below
- Benchmark Electronics Reports Results for the Quarter Ended September 30, 2008
- Benchmark Electronics, Inc. Appoints Clay C. Williams to the Board of Directors
More News related to EZPW
- EZCORP Completes Acquisition of Eleven Nevada Pawnshops
- EZCORP Announces Fiscal 2008 Fourth Quarter and Yearend Results
- Webcast Alert: EZCORP announces EZCORP Fiscal 2008 Fourth Quarter Earnings
- Webcast Alert: EZCORP announces EZCORP Fiscal 2008 Fourth Quarter Earnings
- Matrix USA Rating Changes 10/2
More News related to Upgrades
- BMO Upgrades Spectrum Brands (SPC) to Market Perform
- Maxim Upgrades Palomar Medical (PMTI) to Buy
- RBC Capital Upgrades DSP Group (DSPG) to Sector Perform
- UBS Upgrades Morgans Hotel Group (MHGC) to Buy
- Janney Montgomery Scott Upgrades Wright Express Corp (WXS) to Buy.
Upgrades:
Ameron Int'l (NYSE: AMN) from Sell to Hold, citing new financials 10Q; OGE Energy (NYSE: OGE) from Hold to Buy, citing a declining stock price; Benchmark Electronics (NYSE: BHE) from Hold to Buy, citing a declining stock price; Harsco (NYSE: HSC) from Buy to Strong Buy, citing a declining stock price; Whiting Petroleum (NYSE: WLL) from Hold to Strong Buy, citing an analyst review;
Downgrades:
Thor Industries (NYSE: THO) from Buy to Hold, citing an analyst review; Hormel Foods (NYSE: HRL) from Strong Buy to Buy, citing a rising relative value; EZCorp (Nasdaq: EZPW) from Buy to Hold, citing a rising stock price; Masco (NYSE: MAS) from Hold to Sell, citing a rising relative value; Valeant Pharmaceuticals (NYSE: VRX) from Sell to Strong Sell, citing a rising stock price;
Related Categories
DowngradesUpgrades
Stocks Mentioned
+3.16
-0.47Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
